Last reviewed 2026-04-20 · How we verify

Vancomycin 125mg

At a glance

Approved indications

No approved indications tracked.

Common side effects

• Fatigue
• Arthralgia
• Pruritus
• Abdominal pain
• Flatulence
• Diarrhoea
• Nausea
• Constipation
• Back pain
• Pain in extremity
• Decreased appetite
• Headache

Key clinical trials

• Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas (PHASE1)
• A Phase 1b Trial to Evaluate the Safety of MB310 in Patients With Active, Mild-to-Moderate Ulcerative Colitis (PHASE1)
• Vancomycin Taper to Prevent Recurrent Clostridioides Difficile (PHASE3)
• Initial Vancomycin Taper for the Prevention of Recurrent Clostridium Difficile Infection (PHASE3)
• Combination Study of Antibiotics With Enzalutamide (PROMIZE) (PHASE1, PHASE2)
• Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients (PHASE2, PHASE3)
• Use of Fidaxomicin Compared to Vancomycin for Decolonization of C. Difficile in Patients With Inflammatory Bowel Disease (PHASE4)
• A Phase 1b Trial to Evaluate Safety of MB097 in Combination With Pembrolizumab in Melanoma Patients (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• Vancomycin 125mg CI brief — competitive landscape report
• Vancomycin 125mg updates RSS · CI watch RSS
• Riverside University Health System Medical Center portfolio CI